Shemansky Jm
Researcher
Also affiliated: United States Food and Drug Administration (2025)
Graduate Student Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shemansky Jm's research focuses on assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs. This work investigates the sufficiency of available data for informing risk assessment in this area. The researcher's most recent publication was in 2025, indicating recent activity in the field.
Metrics
- Publications: 1
Selected Publications
-
Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment? (2025)
Collaboration Network
Top Collaborators
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
Similar Researchers
Based on overlapping research topics